Skip to main content
Caplight Logo









BioSerenity

BioSerenity

Private
ParisHealthcare & Life Scienceshttps://bioserenity.ai/

Last Round

Recap

Nov 13, 2023

Total Funding Raised

$94.1M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

BioSerenity is a medical technology company that develops connected medical devices and AI-powered digital health solutions for remote patient monitoring in neurology, cardiology, and sleep disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Telemedicine, Health IoT, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting, Hardware Sales

AI Layer

Foundation

Keywords

neurodiagnosticremote patient monitoringEEG monitoringmedical AIhardware-as-a-serviceHaaStelemedicinecardiac monitoringfoundation modelfrontier AI labwearable medical devicehealth IoTcompanion diagnosticselectrophysiological signalsclinical trial software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioSerenity Comparables

Compare BioSerenity with similar companies based on industry and business-model similarity.

BioSerenity comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stratus
84%
Zeto, Inc.
81%
Seer Medical
78%

BioSerenity Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
RecapNov 13, 2023
Series BJun 18, 2019
Series ASep 20, 2017
SeedJun 8, 2015

Key People

Founding team and executive leadership

Jean-Yves Lagarde

US CEO

Executive Team

Pierre Emerich

Chief Technology Officer

Executive Team

Olivier Auton

Group CFO

Executive Team

Damien MICHON

COO Directeur Des Operations

Executive Team

BioSerenity Investors

Notable investors and investment history

BioSerenity investors
InvestorRounds
Idinvest PartnersSeries A, Series B, Seed
Dassault SystèmesSeries B
Jolt CapitalRecap
LBO FranceSeries B, Series A
BpifranceSeries A, Series B
Kurma PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2026

    New sleep center planned for Auxerre, France in September 2026.

  • Jun 24, 2026

    Monthly visitors grew 35% MoM, reaching 8.4K.

Recent news

Latest coverage and updates

  • is_developingJul 1, 2026

    BioSerenity Medical Devices Group is developing AI-based tools to support clinical decision-making using EEG foundation models on Feb 19th '26.

  • receives_awardJul 1, 2026

    Colin Flipo at BioSerenity Medical Devices Group received award Best Poster Presentation Award at International Conference on Signal, Image Processing and Pattern Recognition on Feb 1st '26.

  • attends_eventJul 1, 2026

    BioSerenity Medical Devices Group attended event International Conference on Signal, Image Processing and Pattern Recognition on Feb 1st '26.

BioSerenity Filings

Explore SEC and related filing metadata, where available.

BioSerenity filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BioSerenity's valuation, stock price, and market status.

Is BioSerenity a public or private company?

BioSerenity is a private company.

What is the current stock price of BioSerenity?

BioSerenity is a private company with no public stock price. No recent secondary market data is available.

How much is BioSerenity worth (valuation)?

Valuation information for BioSerenity is not publicly available.

Can I buy BioSerenity stock?

BioSerenity shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BioSerenity's last funding round?

BioSerenity's most recent funding round was Private Equity on November 13, 2023.

Who are the main investors in BioSerenity?

Key investors in BioSerenity include Idinvest Partners, Dassault Systèmes, Jolt Capital, LBO France, Kurma Partners.

Will BioSerenity IPO soon?

No public IPO plans have been announced for BioSerenity.

How can I track BioSerenity secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioSerenity's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range273
Year Founded2014
Last FundingNov 13, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?